Catalyst Wire Dossier Catalyst Wire Dossier

Contrave (naltrexone SR / bupropion SR)

naltrexone; bupropion · Orexigen Therapeutics, Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Contrave (naltrexone SR / bupropion SR), covering 2015-11-26 to 2015-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects [Phase 3]

See pricing